NCT Number: NCT06074510
Phase: PHASE4
Trial Summary: The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the prostate gland in men wit – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): Lantheus Medical Imaging
Acronym: MIRROR
PYLARIFYA® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives